News
Edinburgh Napier University and biotech firm AlgiSys announce collaboration
A new partnership between Edinburgh Napier University (ENU) and Scottish American biotechnology company AlgiSys will aim to harness the environmental potential of algae to address global pressures on food supply.
AlgiSys’ innovative technology uses biomass fermentation of microalgae to create a clean, vegan source of EPA rich omega-3s and plant protein. Omega-3s are commonly found in fish oil and have widespread health benefits for humans, animals and fish.
Leading lights of life sciences sector to meet in Glasgow
The Scotsman, in partnership with headline sponsor IQVIA, will hold its flagship Life Science Conference 2025 at The Social Hub in Glasgow’s Merchant City on Thursday 27th November. It is described as essential for anyone interested in the future of personalised medicine, biotech entrepreneurship, data-driven healthcare, and green innovation.
Source: The Scotsman
Why collaboration will be key to driving biotech growth
Biotechnology in Scotland is stepping out of the shadows. No longer a specialist sector, it has become an essential lever for public health, climate resilience and economic renewal. Life sciences now touch every aspect of modern life, from infection prevention and advanced diagnostics to sustainable materials and digital therapeutics
Source: The Scotsman
Developing the UK-ADB food and nature partnership
In mid-July, a senior delegation from the Asian Development Bank (ADB) embarked on a UK mission with a series of business meetings at venues across the UK, designed to develop the ADB–UK Food and Nature Partnership launched earlier in the year by the Foreign, Commonwealth and Development Office (FCDO) and ADB.
This partnership aims to advance investments in biodiversity, ecosystems, and food systems transformation.
MYGroup enters joint venture with Beta Bugs to secure supply of Black Soldier Fly eggs
MYGroup has entered into a joint venture with insect genetics company Beta Bugs to supply eggs for its Black Soldier Fly (BSF) bioconversion Insectology™ process for food waste management.
Under the joint venture, Beta Bugs will become MYGroup’s exclusive supplier of BSF eggs, with a new breeding and hatching facility to be established at the waste management company’s The Maltings site at South Milford, near Leeds.
Scottish biotech start-ups are struggling to commercialise
The MRI scanner. Insulin. Football dugouts. All cultivated in Aberdeen.
All having a global impact, providing inspiration for further innovation – and all a small snapshot of what just one Scottish city has given the world.
Source: Business Insider
Scottish biotech company secures £3.4 million
Scottish biotech engineering company uFraction8 has secured £3.4m in new investment, following the completion of a funding round led by Foresight Group.
Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production, offering an energy-efficient alternative to traditional methods used in the production of food, feed and bio-based products.
Source: Business Insider
Scottish biotechnology centre achieves 300 member milestone ahead of major event
Scotland’s Industrial Biotechnology Innovation Centre (IBioIC) has seen its membership surge to more than 300 after welcoming around 100 new members to its network in 2024.
Industry leaders said the growth reflected the health of Scotland’s bio-economy, with start-ups Vaste and Seastex recently joining IBioIC and helping to push its network past the milestone figure.
Source: The Scotsman
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million
An Edinburgh-based biotech pioneer behind technology described as the “holy grail for emerging gene therapies” has been given a £3 million funding injection.
Concinnity Genetics - co-founded by Jessica Birt and Matthew Dale - has developed novel control mechanisms using a cutting-edge artificial intelligence (AI) platform and its synthetic biology expertise.
Source: The Scotsman
Cytomos secures £5 million for scale-up
Midlothian-based biotechnology company Cytomos has secured £5 million to scale up production of its cell analysis technology.
Cytomos said that the investment will enable it to drive sales of its first commercial product, Celledonia™, built on its cell analysis technology platform, AuraCyt, which is “already generating significant market traction.”